Susquehanna International Group, LLP Eye Point Pharmaceuticals, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2024
A detailed history of Susquehanna International Group, LLP transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 49,077 shares of EYPT stock, worth $426,969. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,077
Previous 266,031
81.55%
Holding current value
$426,969
Previous $6.15 Million
83.5%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding EYPT
# of Institutions
176Shares Held
53.9MCall Options Held
764KPut Options Held
1.57M-
Cormorant Asset Management, LP Boston, MA6.89MShares$60 Million8.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.76MShares$41.4 Million0.19% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.76MShares$32.7 Million3.33% of portfolio
-
Franklin Resources Inc San Mateo, CA3.39MShares$29.5 Million0.02% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$24.3 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $296M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...